Tatva Chintan Pharma Chem Limited — Board Meeting, 25-10-2024: Outcome of Board Meeting

Tatva Chintan Pharma Chem Limited reported its standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2024. Key figures include a revenue of ₹809.60 million and a loss before tax of ₹15.77 million. The Board of Directors and Audit Committee reviewed and approved the results, supported by a limited review report from the statutory auditors. Detailed financial statements are available on the company’s website.